NFKB1 and mantle cell lymphoma: We stimulated Jeko-1, Granta-519 and MCL patients B cells with anti-IgM to fully activate the BCR and NF-κB signaling, and we performed immunoprecipitation and immunofluorescence experiments using CARD11 and CK1α antibodies.